Clinical Trial · NCT04176016

Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial Sarcoma

Overview

The purpose of this study is to evaluate safety and pharmacokinetics as well as the biodistribution of OTSA101-DTPA-111In and to evaluate the safety of intravenous administration of OTSA101-DTPA-90Y.

Sponsor

OncoTherapy Science, Inc

Phase

Phase 1

ClinicalTrials.gov

NCT04176016